JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8 T cells in renal cell carcinoma patients. - sprookjes - yvandenbroek - TriplyDB

JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8 T cells in renal cell carcinoma patients.

JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8 T cells in renal cell carcinoma patients.

http://www.wikidata.org/entity/Q33747097

about

Tumor infiltrating CD8(+) T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma Signal transducer and activator of transcription-5 mediates neuronal apoptosis induced by inhibition of Rac GTPase activity.miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction.Effects of Di-(2-ethylhexyl) Phthalate on Lipid Metabolism by the JAK/STAT Pathway in Rats Intrinsic immune alterations in renal cell carcinoma and emerging immunotherapeutic approaches.Identification and Optimization of Combinatorial Glucose Metabolism Inhibitors in Hepatocellular Carcinomas.TIPE2 mRNA overexpression correlates with TNM staging in renal cell carcinoma tissues.Balance of CD8+ CD28+ / CD8+ CD28- T lymphocytes is vital for patients with ulcerative colitis.

P2860

Q35798941-A450921F-6BBB-4207-9D3D-C71E0B626B81 Q35956715-5C6549E4-AC4A-4095-B4CF-947F42423AEA Q36785683-56608982-72AE-40D6-8C30-517648F2E791 Q37455675-25FF905C-75C1-46A2-BE79-0AE8C4890039 Q38099023-39134437-10A2-43A0-BF55-E7A5AB85DFF8 Q38893018-140BE186-EE22-430E-8AAF-F5B2EE9980A5 Q42083370-AB9B05DA-72FC-442A-B0FD-36CC6C278F49 Q44111082-BA0ED427-31AA-43D3-8718-4DED7B63CF50

P2860

JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8 T cells in renal cell carcinoma patients.

http://www.wikidata.org/entity/Q33747097

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

JAK3/STAT5/6 pathway alteratio ...... renal cell carcinoma patients.

@ast

JAK3/STAT5/6 pathway alteratio ...... renal cell carcinoma patients.

@en

type

label

JAK3/STAT5/6 pathway alteratio ...... renal cell carcinoma patients.

@ast

JAK3/STAT5/6 pathway alteratio ...... renal cell carcinoma patients.

@en

prefLabel

JAK3/STAT5/6 pathway alteratio ...... renal cell carcinoma patients.

@ast

JAK3/STAT5/6 pathway alteratio ...... renal cell carcinoma patients.

@en

P1433

Q33747097-F5CE231B-AE24-4EF2-B7E2-A56116CF73D4

P1476

Q33747097-E629F287-28D2-44AA-B8A7-1C17DEDE2D37

P2093

Q33747097-36E68956-3F14-4C4F-9691-A1A6059C2667

Q33747097-3E1C808A-697A-49CD-BD88-9E7DDEAEC3A4

Q33747097-8D895203-6F29-44A7-833F-0DD443F1FBFC

Q33747097-92A0C5F1-4209-4919-AA82-4A15B2E35BA3

Q33747097-9D7C29A7-10B2-46E6-B80A-946F24CAC088

Q33747097-B95FE4C8-BC57-486B-AF7A-2E0C5AAA6544

Q33747097-FCD91781-302A-4941-8E76-5A451BF6DA92

P2860

Q33747097-126A5C04-5FAC-496A-80A8-72D6C3561BC5

Q33747097-1476F91D-CDBD-4485-9D3F-F8F1316F6670

Q33747097-18E7D867-74BE-42DB-88E9-B363CA29F7A8

Q33747097-1FC9D03E-D521-4AAC-8C14-0229BE7DED72

Q33747097-23BABC82-83B1-4F1E-B18B-6198A3221E23

Q33747097-34A13E64-AE86-4733-A995-A00300005F53

Q33747097-4605A30E-A7BF-4DC4-B64B-F0CDA5441F28

Q33747097-4B8E0279-91FC-48FE-9833-3A3FF53B0932

Q33747097-5191E6DC-05AA-4B71-8303-EF90E33F6874

Q33747097-5CFA42DE-67DE-4093-A343-7E4AF9D02431

P304

Q33747097-3A03EE3A-EB98-4C5B-852C-94327A737DFA

P31

Q33747097-4BF2F18C-888A-4A3A-B89C-C0E59722C331

P356

Q33747097-1562E654-8A1A-47C5-9EB2-66988CA2CED2

P478

Q33747097-F971FD9B-B5A8-4EF8-9E54-E7EAD37E8129

P50

Q33747097-5190DD0E-0CA7-48FF-AEE5-BCA04D8FF055

Q33747097-58F7BFC5-826F-4BA9-82FB-DDA0A8CFE3A8

Q33747097-C6CC678C-4A6B-40DA-8BEE-459FFAF03871

Q33747097-D0557C38-3E77-46B5-88DC-CB61AF5400E3

Q33747097-D46B9CCF-BE6F-4726-B683-9DFBD70A8FF9

P577

Q33747097-469CF9CA-A281-4104-8C86-E0782C419B01

P5875

Q33747097-21FB4367-9F6D-4D96-A49A-1E2DAE583AE7

P698

Q33747097-BF470B96-ED38-4A7D-BC70-CE5CFA66C491

P932

Q33747097-D8B2E2CA-9B17-4777-AA8E-5A19EE3FC369

P356

P1433

Journal of Biomedicine and Biotechnology

P1476

JAK3/STAT5/6 pathway alteratio ...... renal cell carcinoma patients

@en

P2093

Carmela Capobianco

http://www.w3.org/2001/XMLSchema#string

Elena Ranieri

http://www.w3.org/2001/XMLSchema#string

Elisabetta Cavalcanti

http://www.w3.org/2001/XMLSchema#string

Francesco P Selvaggi

http://www.w3.org/2001/XMLSchema#string

Margherita Gigante

http://www.w3.org/2001/XMLSchema#string

Raffaele I Cincione

http://www.w3.org/2001/XMLSchema#string

Wolfgang Herr

http://www.w3.org/2001/XMLSchema#string

P2860

Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins

E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control

Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets

The regulation of E2F by pRB-family proteins

Central memory and effector memory T cell subsets: function, generation, and maintenance

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression.

Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression.

P304

935764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2010/935764

http://www.w3.org/2001/XMLSchema#string

P478

2010

http://www.w3.org/2001/XMLSchema#string

P50

Walter J. Storkus

Loreto Gesualdo

Michele Battaglia

Pasquale Ditonno

P577

2010-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42589597

http://www.w3.org/2001/XMLSchema#string

P698

20339477

http://www.w3.org/2001/XMLSchema#string

P932

2843943

http://www.w3.org/2001/XMLSchema#string